201 related articles for article (PubMed ID: 15913747)
1. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.
Isobe T; Hattori T; Kitagawa K; Uchida C; Kotake Y; Kosugi I; Oda T; Kitagawa M
J Biol Chem; 2009 Oct; 284(41):27766-27779. PubMed ID: 19679664
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
5. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
[TBL] [Abstract][Full Text] [Related]
6. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
9. hCDC4 variation in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
[TBL] [Abstract][Full Text] [Related]
10. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
[TBL] [Abstract][Full Text] [Related]
11. hCDC4 gene mutations in endometrial cancer.
Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI
Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400
[TBL] [Abstract][Full Text] [Related]
12. Fbw7 isoform interaction contributes to cyclin E proteolysis.
Zhang W; Koepp DM
Mol Cancer Res; 2006 Dec; 4(12):935-43. PubMed ID: 17189384
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
14. The Fbxw7/hCdc4 tumor suppressor in human cancer.
Tan Y; Sangfelt O; Spruck C
Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
[TBL] [Abstract][Full Text] [Related]
15. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines.
Moberg KH; Bell DW; Wahrer DC; Haber DA; Hariharan IK
Nature; 2001 Sep; 413(6853):311-6. PubMed ID: 11565033
[TBL] [Abstract][Full Text] [Related]
16. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
17. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
[TBL] [Abstract][Full Text] [Related]
19. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
